4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-031542
CEO and Chairman sold 150,000 shares at an average $40.23 ($6,034,424)
- CEO and Chairman acquired 150,000 shares (option exercise)
- CEO and Chairman gave 100,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-19 | Exercise or conversion : show line 1 in the form | +50,000 | $0.33 | $16,500 | 1,928,180 | D |
| 2020-05-19 | Sale : show line 2 in the form | −900 | $39.31 | $35,379 | 1,927,280 | D |
| 2020-05-19 | Sale : show line 3 in the form | −49,100 | $39.95 | $1,961,545 | 1,878,180 | D |
| 2020-05-20 | Exercise or conversion : show line 4 in the form | +50,000 | $0.33 | $16,500 | 1,928,180 | D |
| 2020-05-20 | Sale : show line 5 in the form | −50,000 | $40.46 | $2,023,000 | 1,878,180 | D |
| 2020-05-21 | Exercise or conversion : show line 6 in the form | +50,000 | $0.33 | $16,500 | 1,928,180 | D |
| 2020-05-21 | Sale : show line 7 in the form | −50,000 | $40.29 | $2,014,500 | 1,878,180 | D |
| 2020-05-21 | Gift : show line 8 in the form | −100,000 | 1,778,180 | D | ||
| Open-market sales · 150,000 sh · avg $40.23 · $6,034,424 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-19 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −50,000 | 551,560 | D |
| 2020-05-20 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −50,000 | 501,560 | D |
| 2020-05-21 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −50,000 | 451,560 | D |
Loading xslF345X03/doc4.xml…